Many auto dealers are speaking out against the Tesla business model. CNBC's Bertha Coombs reports what Tesla customers are saying after the New Jersey Motor Vehicles Commission's voted to ban the direct sale of automobiles in the state.» Read More
GlaxoSmithKline is seeing strong, double-digit growth from sales in emerging markets, offsetting sales declines from generic drugs in the U.S. and Europe, Chief Executive Andrew Witty told CNBC Tuesday.
Emerging-market sales are helping to drive Johnson & Johnson's growth, but the company is not forgetting the developed world, Chairman William Weldon told CNBC Tuesday.
CNBC's Melissa Lee and the Fast Money traders discuss the day's top trades and the stocks they'll be watching tomorrow.
Stocks ended modestly lower amid further signs of economic weakness, and despite a positive call on commodities by Goldman Sachs, which lifted prices of oil and metals.
The price? The government's break-even is $28.70; everyone seems to agree they will price above that. The bigger problem, for fundamental holders, is the float.
Discussing investment strategies for volatile markets as summer approaches, with Harry Clark, Clark Capital Management, and Ronald Albahary, Convergent Wealth Advisors. Could this be the year to sell in May and walk away?
Stocks turned modestly lower before the close amid more news of weakness in the nation's manufacturing sector, and a positive call on commodities by Goldman Sachs lifted prices of oil and metals.
An investment strategy that plays on China's energy shortages, with Brian Kelly, Brian Kelly Capital founder & president.
Uncertainty is taking over Wall Street. Stocks were up in early trading but gave back most of those gains. Is this a case of market correction or seasonal lows? Peter Andersen, Congress Asset Management Company, and Greg Olsen, Lenox Advisors Partner weigh in.
Discussing GSK's plans to reinvest 20% of its profits from less developed countries to improve health care; global opportunities, and new growth models, with Andrew Witty, GlaxoSmithKline CEO
"Maybe we've all died and gone to hell, and this is hell," one despondent trader said to me.
Financial stocks overall saw a big jump in short-selling activity at the end of April. The Financial Select Sector SPDR saw an increase in outstanding short interest to 112 million shares from nearly 91 million in the middle of the month, according to New York Stock Exchange data. ...A report from TheStreet.
For the first time in at least eight months, investors are not treating the latest stock downturn as a buy-the-dips opportunity.
With risk appetite waning, here's what one trader sees for Asian currencies. Hint: it's not what you think.
Greece debt problems and the U.S. dollar are driving market action today. Insight on how to play the volatile markets, with Sean Kraus, Citizens Trust, and David Gilmore, Foreign Exchange
Finding value in a post-QE2 market, with Bradley Hinton, Weitz Partners.
Finding growth opportunities in uncertain markets, with Robert Pavlik, Banyan Partners, and Nicholas Colas, ConvergEx.
CNBC's Mary Thompson breaks downs the numbers on the new insurance giant.
Breaking down the numbers on Russia's version of Google, with CNBC's Bertha Coombs.
CNBC's Rick Santelli reports on today's 2-year Treasury auction and other activity in the bond market.